Hexagon Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-69
| Closed | -$33.5K | – | 1693 |
|
|
2025
Q1 | $33.5K | Sell |
69
-4
| -5% | -$1.94K | 0.01% | 586 |
|
|
2024
Q4 | $29.4K | Sell |
73
-50
| -41% | -$20.1K | 0.01% | 649 |
|
|
2024
Q3 | $57.2K | Sell |
123
-13
| -10% | -$6.05K | 0.01% | 424 |
|
|
2024
Q2 | $63.7K | Sell |
136
-2
| -1% | -$937 | 0.01% | 380 |
|
|
2024
Q1 | $57.7K | Buy |
138
+59
| +75% | +$24.7K | 0.01% | 399 |
|
|
2023
Q4 | $32.1K | Buy |
79
+2
| +3% | +$814 | 0.01% | 516 |
|
|
2023
Q3 | $26.8K | Hold |
77
| – | – | 0.01% | 488 |
|
|
2023
Q2 | $27.1K | Hold |
77
| – | – | 0.01% | 484 |
|
|
2023
Q1 | $24.3K | Hold |
77
| – | – | 0.01% | 500 |
|
|
2022
Q4 | $22.2K | Sell |
77
-63
| -45% | -$18.2K | 0.01% | 517 |
|
|
2022
Q3 | $41K | Hold |
140
| – | – | 0.01% | 427 |
|
|
2022
Q2 | $39K | Hold |
140
| – | – | 0.01% | 416 |
|
|
2022
Q1 | $37K | Hold |
140
| – | – | 0.01% | 409 |
|
|
2021
Q4 | $31K | Hold |
140
| – | – | 0.01% | 429 |
|
|
2021
Q3 | $25K | Sell |
140
-87
| -38% | -$15.5K | 0.01% | 452 |
|
|
2021
Q2 | $46K | Buy |
227
+8
| +4% | +$1.62K | 0.01% | 337 |
|
|
2021
Q1 | $47K | Hold |
219
| – | – | 0.01% | 317 |
|
|
2020
Q4 | $51K | Hold |
219
| – | – | 0.02% | 267 |
|
|
2020
Q3 | $45K | Buy |
+219
| New | +$45K | 0.01% | 267 |
|